Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US fetal monitoring market boom expected:

This article was originally published in Clinica

Executive Summary

US sales of stand-alone fetal monitoring systems and disposable sensors are expected to rise to $69.8 million by 2003, a threefold increase from this year's projected sales of $16.7 million. The introduction of two new technologies - fetal pulse oximetry, which will be used in intrapartum foetal monitors and non-invasive bilirubin screening - will also contribute to the expansion of the $249 million US neonatal/perinatal products market. Non-invasive bilirubin screening is expected to create a $16.3 million US market in the first year of launch (2000) and increase in value to $34.9 million by 2003, reports MedPro Monthly.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel